Abstract
Cystine knot microproteins are promising novel scaffolds for the oral delivery of pharmacophoric sequences. In order to cross mucosal membranes, these scaffolds should be stable towards membrane bound enzymes (MBE) of the intestinal mucosa. Therefore, two novel cystine-knot microprotein scaffolds have been evaluated regarding their stability towards MBE of excised rat small intestine and the most abundant membrane bound exopeptidase aminopeptidase N. It was shown, that SE-ET-TP-020 (37 amino acids) is degraded by membrane bound enzymes of rat intestinal mucosa, whereas SE-MC-TR-020 (32 amino acids) is not degraded by these enzymes. Neither of the two evaluated scaffolds was degraded by aminopeptidase N. The results of this study further support the hypothesis that scaffolds with 37 amino acids are more susceptible towards MBE caused degradation in comparison to scaffolds with about 30 amino acids.
Keywords: aminopeptidase N, HPLC, Enzymatic Stability, Cystine knot microproteins (CKM), membrane bound enzymes (MBE)
Letters in Drug Design & Discovery
Title: Relation Between Scaffold Size and Membrane Bound Enzyme Caused Degradation of Two Novel Cystine Knot Microproteins
Volume: 4 Issue: 1
Author(s): Martin Werle, Harald Kolmar and Andreas Bernkop-Schnurch
Affiliation:
Keywords: aminopeptidase N, HPLC, Enzymatic Stability, Cystine knot microproteins (CKM), membrane bound enzymes (MBE)
Abstract: Cystine knot microproteins are promising novel scaffolds for the oral delivery of pharmacophoric sequences. In order to cross mucosal membranes, these scaffolds should be stable towards membrane bound enzymes (MBE) of the intestinal mucosa. Therefore, two novel cystine-knot microprotein scaffolds have been evaluated regarding their stability towards MBE of excised rat small intestine and the most abundant membrane bound exopeptidase aminopeptidase N. It was shown, that SE-ET-TP-020 (37 amino acids) is degraded by membrane bound enzymes of rat intestinal mucosa, whereas SE-MC-TR-020 (32 amino acids) is not degraded by these enzymes. Neither of the two evaluated scaffolds was degraded by aminopeptidase N. The results of this study further support the hypothesis that scaffolds with 37 amino acids are more susceptible towards MBE caused degradation in comparison to scaffolds with about 30 amino acids.
Export Options
About this article
Cite this article as:
Werle Martin, Kolmar Harald and Bernkop-Schnurch Andreas, Relation Between Scaffold Size and Membrane Bound Enzyme Caused Degradation of Two Novel Cystine Knot Microproteins, Letters in Drug Design & Discovery 2007; 4 (1) . https://dx.doi.org/10.2174/157018007778992874
DOI https://dx.doi.org/10.2174/157018007778992874 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Elevated Interleukin 37 Expression Associated With Disease Activity in HLA-B27 Associated Anterior Uveitis and Idiopathic Anterior Uveitis
Current Molecular Medicine The Challenge of Antiretroviral-Drug-Resistant HIV: Is There Any Possible Clinical Advantage?
Current HIV Research Astrocytes Exert and Control Immune Responses in the Brain
Current Immunology Reviews (Discontinued) Comparative Bioavailability Study of a New Formulation of Injection of 75 mg Diclofenac Sodium in 1 mL with the Conventional Injection of 75 mg Diclofenac Sodium Given in 3 mL Volume
Current Clinical Pharmacology Are the Extracelluar Pathways a Conduit for the Delivery of Therapeutics to the Brain?
Current Pharmaceutical Design New Insights in Drug-Induced Mitochondrial Toxicity
Current Pharmaceutical Design Structures and Properties of Multi-stranded Nucleic Acids
Current Organic Chemistry Curcumin Combats against Organophosphate Pesticides Toxicity: A Review of the Current Evidence and Molecular Pathways
Current Medicinal Chemistry Taking a Systems Approach to the Identification of Novel Therapeutic Targets and Biomarkers
Current Pharmaceutical Biotechnology Immunogenicity Assessment of Therapeutic Proteins and Peptides
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neutrophil Function in Severe Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Autoimmunity and Frontotemporal Dementia
Current Alzheimer Research Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Inhibitors of Endocannabinoid Degradation as Potential Therapeutic Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Pediatric Eosinophilic Esophagitis: Epidemiology, Diagnosis and Treatment
Current Pediatric Reviews Chemical Composition, Antioxidant and Anti-inflammatory Activity Evaluation of the Lebanese Propolis Extract
Current Pharmaceutical Biotechnology A Review of Type 2 Diabetes Mellitus Predisposing Genes
Current Diabetes Reviews Nanocarriers: A General Strategy for Enhancement of Oral Bioavailability of Poorly Absorbed or Pre-Systemically Metabolized Drugs
Current Drug Metabolism